The fraction of Ki67‐positive tumor cells (Ki67 labeling index, Ki LI) has been proven to be an established prognostic marker for various tumor types, especially in breast cancer (Hu et al., 2017; Li et al., 2017). This evidence concerns the gene MKI67 and breast carcinoma.